Protagonist Therapeutics Aktie
41,40
EUR
+1,40
EUR
+3,50
%
47,86
USD
+0,90
USD
+1,92
%
Werbung
Protagonist Therapeutics Aktie Analyse
08.07.19 | Protagonist Therapeutics Buy | H.C. Wainwright & Co. | |
22.02.19 | Protagonist Therapeutics Outperform | BMO Capital Markets | |
29.01.18 | Protagonist Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
21.07.17 | Protagonist Therapeutics Buy | BTIG Research | |
06.09.16 | Protagonist Therapeutics overweight | Barclays Capital |
Werbung
Werbung